Zatkovich & Associates conducts retained search assignments for established "high tech" and emerging technology companies. We are interested in hearing from professionals with National, International, major account/regional sales management, business development, marketing and engineering experience at the following levels: Director, VP, CMO, CFO, CIO, COO, CTO, and President/CEO.

We request you submit your resume and cover letter in confidence to ZakAssoc@aol.com. Specify desired level of responsibility, areas of interest, technology, company size and geographic preferences.

Zatkovich & Associates does not submit resumes to any of its clients without the candidate.s knowledge, or approval.

Director or VP Level - Marketing, Program/Project Management

Headquartered in the heart of Silicon Valley, California, this industry leader designs and manufactures microwave sources: Frequency Synthesizers, Voltage Controlled Oscillators (VCO.s) and custom Microwave Assemblies in the 1-40 GHz spectrum.

Specific market applications:
* Air/Sea/Ground based communication systems
* EW, SIGINT and other military applications
* Telecom infrastructure
* Test equipment and industrial controls

This newly created position will report directly to the President.

Scope: This individual will play a key role in the strategic marketing/business development and program/product management of the next generation RF/Microwave sources for the security, defense and industrial electronics markets. This high visibility position will include responsibility for leading projects through the complete product life cycle with cross functional management responsibilities.

Focus will be on this person's ability to work primarily with clients who have unique requirements not being addressed by "standard" signal source devices. Together with other members of the management staff, this industry professional will contribute to setting the strategic direction of the company while promoting the technological advantage of this promising company.

Emphasis will be on an "in-the-trenches" ...."roll up your sleeves" individual who gets the job done, while working closely with other members of the executive management team to insure overall objectives are met.




ACQUISITIONS - INVESTMENT OPPORTUNITIES

Equity partners, LLC.s, Angel/Institutional Investors, or Corporations requesting additional information regarding any of the below profiled investment opportunities, or acquisitions please contact: Gary A. Zatkovich, Managing Partner: ZakAssoc@aol.com, or call 707-577-8317. ________________________________________________________________________



Company A - Founded in 1999, this privately held human factors engineering and R&D firm specializes in the development of advanced interface technology for wearable computing and robotic control systems as well as the design, development, and testing of simulation tools for training applications. They hold numerous patents and all IP rights. The company has implemented a strategy of using its core technology to capture government grants and contracts to build a portfolio of intellectual property and products with the goal of commercialization in the defense, education, and rehabilitation markets. Among the Department of Defense projects is development and integration of robotic control technologies, and virtual simulation training.
Customers include the U.S. Army, Navy, and Marines, DARPA, Lockheed Martin, and NASA, and supported government programs such as Digital Military Police, Augmented Cognition, Tactical Mobile Robots, Gladiator, and Future Force Warrior. Additionally, the National Institute of Health (NIH) and the Department of Education, and the National Science Foundation (NSF) are also customers of the company. In 2008 AnthroTronix began to providing and marketing its technology services to commercial companies.
A subsidiary company designs, manufactures, markets, and distributes rehabilitation and education-related products originating from the R&D initiatives. Clients include: The National Institute of Health (NIH), The Department of Education, and The National Science Foundation (NSF).
This company is seeking to raise $3 - $5 million in equity capital to expand its commercial revenues and market penetration with increased business development targeted to licensing its technology. The company also plans to expand and perfect its intellectual property and patent portfolio base.

________________________________________________________________________

Company B - Founded in 2009, this privately held company designs and manufactures a comprehensive line of anti theft solar panel electronic security systems for its private, government, and commercial customers.
Solar market growth is 35% per year with over 40,000 solar installations in the US, alone. Unfortunately, theft of solar panels is rising at almost an identical rate. Theft deterrents available today range from a verity of safety nuts and fasteners to fences, video surveillance and alarm systems. To date, none of these security measures have proven to be very effective. This company.s patent pending solution is the only proven Solar Security system of its kind on the market today.
Revenues are in the mid six figures (60% - 70% margins) since commencing operations Nov. 2009. They are seeking strategic partners, and/or $500K in equity funding.

Seeking $30M+ in additional funding to meet the demand for $1.3B in pending orders. ________________________________________________________________________

Company C - This privately held, year old start up develops and manufacturers reagent consumables for the detection of proteins and nucleic acids by instrumentation of various manufacturers. They design, develop and manufacture rapid, cost effective and ease of use assay solutions for the biotechnology industry to aid in the research of diabetes, AIDS, cancer and drug discovery research. This new and improved approach will revolutionize the consumables industry with its patent pending platform and foundation allowing them to incorporate 2 to 3 new quality products every quarter.
The target market includes biotechnology instrument manufacturers, large and mid size pharmaceutical companies, research institutions (including hospitals) and other biotechnology companies both nationally and internationally.
2010 revenues are estimated to be in the mid six figures and they are seeking $1M in funding that will be issued in fully convertible notes.